Amy E. Moran

4.2k total citations · 4 hit papers
46 papers, 2.9k citations indexed

About

Amy E. Moran is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Amy E. Moran has authored 46 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 21 papers in Immunology and 11 papers in Molecular Biology. Recurrent topics in Amy E. Moran's work include Cancer Immunotherapy and Biomarkers (15 papers), Immunotherapy and Immune Responses (12 papers) and Immune Cell Function and Interaction (12 papers). Amy E. Moran is often cited by papers focused on Cancer Immunotherapy and Biomarkers (15 papers), Immunotherapy and Immune Responses (12 papers) and Immune Cell Function and Interaction (12 papers). Amy E. Moran collaborates with scholars based in United States, United Kingdom and Japan. Amy E. Moran's co-authors include Kristin A. Hogquist, Yan Xing, Jennifer A. Punt, Jonathan S. Maltzman, Nicole R. Cunningham, Andrew D. Weinberg, Monica M. Bertagnolli, Adelaide M. Carothers, Mark Redston and Fanny Polesso and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Amy E. Moran

43 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse

2011 769 citations Amy E. Moran, Yan Xing et al. The Journal of Experimental Medicine profile →
Antigen-Independent Differentiation and Maintenance of Effector-like Resident Memory T Cells in Tissues

2012 511 citations Kerry A. Casey, Kathryn Fraser et al. The Journal of Immunology profile →
Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing data

2021 234 citations Duanchen Sun, Xiangnan Guan et al. Nature Biotechnology profile →
Androgen receptor activity in T cells limits checkpoint blockade efficacy

2022 233 citations Xiangnan Guan, Fanny Polesso et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy E. Moran United States	22	1.8k	880	698	287	207	46	2.9k
Laura Bracci Italy	20	1.5k 0.9×	1.2k 1.4×	541 0.8×	210 0.7×	276 1.3×	36	2.6k
Flavio Salazar‐Onfray Chile	34	2.1k 1.2×	1.1k 1.3×	1.1k 1.6×	136 0.5×	159 0.8×	83	3.3k
Alexandre Boissonnas France	32	2.5k 1.4×	1.1k 1.3×	1.0k 1.4×	252 0.9×	423 2.0×	58	3.8k
Hye‐Jung Kim United States	20	1.8k 1.0×	1.0k 1.1×	689 1.0×	136 0.5×	161 0.8×	29	3.0k
Émilie Narni-Mancinelli France	25	2.7k 1.6×	986 1.1×	597 0.9×	137 0.5×	227 1.1×	32	3.4k
Qingfeng Chen Singapore	25	816 0.5×	574 0.7×	623 0.9×	192 0.7×	237 1.1×	72	2.1k
Frédéric Coutant France	17	1.3k 0.7×	665 0.8×	591 0.8×	152 0.5×	429 2.1×	29	2.2k
David Anz Germany	26	1.5k 0.8×	651 0.7×	758 1.1×	111 0.4×	158 0.8×	54	2.3k
Mansi Saxena United States	14	1.5k 0.9×	867 1.0×	872 1.2×	132 0.5×	140 0.7×	26	2.3k
Anders Elm Pedersen Denmark	31	1.4k 0.8×	618 0.7×	914 1.3×	107 0.4×	200 1.0×	87	2.4k

Countries citing papers authored by Amy E. Moran

Since Specialization

Citations

This map shows the geographic impact of Amy E. Moran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy E. Moran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy E. Moran more than expected).

Fields of papers citing papers by Amy E. Moran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy E. Moran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy E. Moran. The network helps show where Amy E. Moran may publish in the future.

Co-authorship network of co-authors of Amy E. Moran

This figure shows the co-authorship network connecting the top 25 collaborators of Amy E. Moran. A scholar is included among the top collaborators of Amy E. Moran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy E. Moran. Amy E. Moran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brown, Emma, Daniella Lefteri, Amy E. Moran, et al.. (2024). Inhibitors of the small membrane (M) protein viroporin prevent Zika virus infection. eLife. 13. 6 indexed citations

Chaudagar, Kiranj, Shenglin Mei, Taghreed Hirz, et al.. (2023). 1537 Androgen blockade primes NLRP3 inflammasome in macrophages to induce tumor cell phagocytosis. SHILAP Revista de lepidopterología. A1760–A1762. 1 indexed citations

Chesner, Lisa N., Julie N. Graff, Fanny Polesso, et al.. (2023). Abstract B041: AR suppresses MHC Class I expression and T-cell response in prostate cancer. Cancer Research. 83(11_Supplement). B041–B041. 2 indexed citations

Polesso, Fanny, et al.. (2023). Abstract NG01: Dendritic cell intrinsic androgen receptor signaling reduces dendritic cell function and anti-tumor immunity. Cancer Research. 83(7_Supplement). NG01–NG01. 2 indexed citations

Sun, Duanchen, Xiangnan Guan, Amy E. Moran, et al.. (2021). Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing data. Nature Biotechnology. 40(4). 527–538. 234 indexed citations breakdown →

Wang, Pengrui, David B. Berry, Zhaoqiang Song, et al.. (2020). 3D Printing of a Biocompatible Double Network Elastomer with Digital Control of Mechanical Properties. Advanced Functional Materials. 30(14). 44 indexed citations

Graff, Julie N., Mark N. Stein, Rishi Surana, et al.. (2020). Phase II Study of Ipilimumab in Men With Metastatic Prostate Cancer With an Incomplete Response to Androgen Deprivation Therapy. Frontiers in Oncology. 10. 1381–1381. 12 indexed citations

Wang, Pengrui, et al.. (2019). Controlled Growth Factor Release in 3D‐Printed Hydrogels. Advanced Healthcare Materials. 9(15). e1900977–e1900977. 63 indexed citations

Polesso, Fanny, et al.. (2019). OX40 Agonist Tumor Immunotherapy Does Not Impact Regulatory T Cell Suppressive Function. The Journal of Immunology. 203(7). 2011–2019. 27 indexed citations

10.

Polesso, Fanny, Andrew D. Weinberg, & Amy E. Moran. (2018). Late-Stage Tumor Regression after PD-L1 Blockade Plus a Concurrent OX40 Agonist. Cancer Immunology Research. 7(2). 269–281. 37 indexed citations

11.

Napier, Ruth J., Ellen J Lee, Emily Vance, et al.. (2018). Nod2 Deficiency Augments Th17 Responses and Exacerbates Autoimmune Arthritis. The Journal of Immunology. 201(7). 1889–1898. 15 indexed citations

12.

Wang, Pengrui, Xin Li, Wei Zhu, et al.. (2018). 3D bioprinting of hydrogels for retina cell culturing. Bioprinting. 12. e00029–e00029. 55 indexed citations

13.

Moran, Amy E., Fanny Polesso, & Andrew D. Weinberg. (2014). OX40 agonist immunotherapy expands tumor reactive CD8 T cells with a unique T cell receptor repertoire and synergizes with PDL-1 blockade to promote tumor regression. Journal for ImmunoTherapy of Cancer. 2(S3). 2 indexed citations

14.

Moran, Amy E., Magdalena Kovacsovics-Bankowski, & Andrew D. Weinberg. (2013). The TNFRs OX40, 4-1BB, and CD40 as targets for cancer immunotherapy. Current Opinion in Immunology. 25(2). 230–237. 131 indexed citations

15.

Casey, Kerry A., Kathryn Fraser, Jason M. Schenkel, et al.. (2012). Antigen-Independent Differentiation and Maintenance of Effector-like Resident Memory T Cells in Tissues. The Journal of Immunology. 188(10). 4866–4875. 511 indexed citations breakdown →

16.

Moran, Amy E. & Kristin A. Hogquist. (2011). T‐cell receptor affinity in thymic development. Immunology. 135(4). 261–267. 60 indexed citations

17.

Meyerson, Joel R., Tommi White, Donald Bliss, et al.. (2011). Determination of Molecular Structures of HIV Envelope Glycoproteins using Cryo-Electron Tomography and Automated Sub-tomogram Averaging. Journal of Visualized Experiments. 15 indexed citations

18.

Moran, Amy E., Yan Xing, Nicole R. Cunningham, et al.. (2011). T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse. The Journal of Experimental Medicine. 208(6). 1279–1289. 769 indexed citations breakdown →

19.

Wirth, Lori J., Jeffrey F. Krane, Yi Li, et al.. (2008). A Pilot Surrogate Endpoint Biomarker Study of Celecoxib in Oral Premalignant Lesions. Cancer Prevention Research. 1(5). 339–348. 19 indexed citations

20.

Carothers, Adelaide M., et al.. (2006). Deficient E-cadherin adhesion in C57BL/6J-Min/+ mice is associated with increased tyrosine kinase activity and RhoA-dependent actomyosin contractility. Experimental Cell Research. 312(4). 387–400. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact